'Smart' nanoparticles as drug delivery systems for applications in tumor therapy

Zhi Fang1, Lin-Yan Wan1,2, Liang-Yin Chu3,4

  • 1a 1 China Three Gorges University, Medical College , Yichang, Hubei 443002, China zhangyanqiong@ctgu.edu.cn ; wujiangfeng@ctgu.edu.cn.

Abstract

Insights

Smart nanoparticles (NPs) offer targeted drug delivery for cancer therapy, improving efficacy and reducing side effects. Careful selection and modification of NPs are crucial for successful tumor treatment strategies.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Oncology

Background:

  • Targeted drug delivery to tumor sites is crucial for maximizing efficacy and minimizing side effects in cancer therapy.
  • Smart nanoparticles (NPs) offer a promising solution due to their ability to undergo conformational changes in response to disease-specific stimuli.
  • This enables targeted and controlled drug release directly at the tumor site.

Purpose of the Study:

  • To review the characteristics of smart NPs as drug delivery systems.
  • To discuss their behavior in targeting, transport, transmembrane passage, and endosomal escape.
  • To highlight their applications in tumor therapy.

Main Methods:

  • Literature review of smart nanoparticle characteristics.
  • Analysis of targeting, transport, and cellular interaction mechanisms.
  • Focus on applications in preclinical and clinical tumor therapy.

Main Results:

  • Smart NPs demonstrate potential for enhanced drug delivery and controlled release in tumor environments.
  • Their ability to respond to specific stimuli facilitates targeted accumulation at the tumor site.
  • Effective endosomal escape mechanisms are critical for intracellular drug delivery.

Conclusions:

  • Biodegradable smart NPs hold significant potential for maximizing therapeutic efficacy and drug availability in tumor therapy.
  • They can substantially reduce adverse effects on healthy tissues.
  • Optimizing NP selection and modification based on tumor treatment strategies is essential for successful clinical translation.

Related Concept Videos

Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
113
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
114
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K